Preclinical studies have demonstrated that MYP not only protects central neurons from stress-induced damage but also relieves fatigue and cognitive impairment by modulating the HPA axis, inhibiting neuroinflammation, and regulating cholinergic activity (Lee et al., 2015; Song et al., 2021). The gene discussed is NOL3; the disease is Cognitive impairment.